Workflow
泽璟制药: 泽璟制药关于使用部分暂时闲置募集资金进行现金管理的公告

Core Viewpoint - The company plans to utilize part of its temporarily idle raised funds for cash management, aiming to enhance fund efficiency and generate additional returns while ensuring the safety and proper use of the funds [2][4][8] Fundraising Overview - The company was approved to publicly issue 60 million A-shares at a price of RMB 33.76 per share, raising a total of RMB 2,025,000,000, with a net amount of RMB 1,908,220,754.68 after deducting issuance costs [3] - In April 2023, the company issued 24,489,795 A-shares at RMB 49.00 per share, raising RMB 1,199,999,955, with a net amount of RMB 1,181,933,181.59 after costs [3] Cash Management Plan - The company intends to use up to RMB 4 billion from the idle funds raised from the initial public offering and up to RMB 8.5 billion from the funds raised through a private placement for cash management [2][5] - The cash management will involve purchasing low-risk, liquid principal-protected financial products or deposit products, ensuring that these funds are not used for pledging or securities investments [4][5] Investment Objectives - The primary goal is to improve the efficiency of fund usage and generate additional income without affecting the implementation of investment projects or the safety of the raised funds [4][6] Decision Validity and Management - The decision is valid for 12 months starting from June 15, 2025, and funds can be rolled over within the specified limits [5] - The company’s financial department is responsible for organizing and implementing the cash management activities [5][6] Impact on Daily Operations - The cash management plan will not affect the normal operation of the company’s main business or the regular turnover of funds [6] - The investment returns will be prioritized for supplementing project funding shortfalls and supporting daily operational liquidity [5][6] Regulatory Compliance - The company will adhere to relevant regulations and timely disclose information as required by the China Securities Regulatory Commission and the Shanghai Stock Exchange [5][8] - The sponsor institution has confirmed that the cash management plan complies with regulatory requirements and does not alter the intended use of the raised funds [8]